Vivos Therapeutics to Launch MyoCorrect Orofacial Myofunctional Therapy Service
Vivos expects to see additional revenue from its new MyoCorrect service in the form of increased Vivos System cases and fees charged for the service.
- Vivos expects to see additional revenue from its new MyoCorrect service in the form of increased Vivos System cases and fees charged for the service.
- Vivos believes the MyoCorrect service will become an important value-added component in the treatment of OSA using the Vivos System.
- Vivos further believes that offering OMT as a service will provide Vivos with an additional competitive advantage in the OSA treatment marketplace.
- Vivos plans to make the MyoCorrect protocol available as a component of the Vivos System and will actively integrate training and implementation protocols for Vivos trained dentists to utilize the MyoCorrect therapy.